Skip to main content
TipRanks
Go Ultimate75% OFF

Madrigal Pharmaceuticals (YDO1) Q2 2026 Earnings Report

0 Followers

CH:YDO1 Q2 2026 EPS Results

Actual EPS
-CHF 1.66
Consensus EPS
-CHF 2.23
Beat/Miss
Beat by +CHF 0.57
One Year Ago EPS
-CHF 1.58

CH:YDO1 Q2 2026 Revenue Results

Actual Revenue
CHF 303.15M
Expected Revenue
CHF 293.06M
Beat/Miss
Beat by +CHF 10.09M
YoY Revenue Growth
+71.17%

Earnings Announcement Details

Quarter
Q2 2026
Date
07/30/2026
Time
Before Open
Conference Call
Thursday, July 30, 2026
CH:YDO1 Upcoming Earnings

Madrigal Pharmaceuticals's next earnings date is estimated for February 25, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

CH:YDO1 Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

CH:YDO1 Earnings History

CH:YDO1 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 25, 20272026 (Q4)1.19--2.14――
Nov 03, 20262026 (Q3)-0.721.52-4.23136.02% (+5.75)
Jul 30, 20262026 (Q2)-2.23-1.66-1.58-4.74% (-0.07)
May 06, 20262026 (Q1)-3.52-2.70-2.762.11% (+0.06)
Feb 19, 20262025 (Q4)-0.74-2.14-2.265.17% (+0.12)
Nov 04, 20252025 (Q3)-1.90-4.23-4.09-3.25% (-0.13)
Aug 05, 20252025 (Q2)-2.96-1.58-5.9173.24% (+4.33)
May 01, 20252025 (Q1)-3.12-2.76-6.1455.01% (+3.38)
Feb 26, 20252024 (Q4)-3.26-2.26-4.7352.29% (+2.47)
Oct 31, 20242024 (Q3)-5.62-4.09-4.447.87% (+0.35)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed